Clinical Trials Directory

Trials / Unknown

UnknownNCT01828892

Glue Application in the Treatment of Low-Output Fistulas

A Randomized Controlled Trial to Evaluate Fibrin Glue Application in the Treatment of Low-Output Enterocutaneous Fistulas

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Jinling Hospital, China · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Adjuvant use of fibrin glue (FG) in the fistula tract has been shown to promote closure of low-output enterocutaneous fistulas (ECFs). The primary objectives of this study are to compare the clinical efficacy, safety of autologous platelet-rich fibrin glue (PRFG), commercial fibrin glue, and control therapy in the management of patients with low-output volume ECFs.

Detailed description

* This is a prospective, randomized, multi-centered study clinical, safety and economic outcome of ECFs patients. * Subjects are randomized to one of 3 groups: * Group 1: Autologous PRFG-treatment \[PRFG + Standard of care (SOC)\] * Group 2: Commercial FG-treatment \[FG + Standard of care (SOC)\] * Group 3: Control (SOC only) * Study will include three phases: * Phase 1: Screening, consent and enrollment * Phase 2: Patients will receive either PRFG, commercial FG, or SOC only for 14 days * Phase 3: Follow up: for patients with closed fistula within 14 days, we will follow up them for 6 months. For patients whose fistulas were still open will be treated with other therapeutic option and follow up for 6 months after closure.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndoscopy exploration and glue applicationA forward-viewing fistula-fiberscope (EndoView, Outai Medical Equipment, Shanghai, China), with 15cm length and 5mm width of fiber optical wire, was inserted into the fistula tract to accomplish endoscopic visualization. Briefly, the fistula-fiberscope assisted procedure was carried out percutaneously, allowing the exposure of internal hole and the whole tracts, followed by insertion of this catheter with distal mixing device.
PROCEDUREEndoscopy explorationA forward-viewing fistula-fiberscope (EndoView, Outai Medical Equipment, Shanghai, China), with 15cm length and 5mm width of fiber optical wire, was inserted into the fistula tract to accomplish endoscopic visualization.
DRUGAntibiotics (ceftazidime, cefotaxime, or meropenem, with or without vancomycin)Antibacterial therapy in patients with signs of systemic sepsis or local inflammation with pain
DIETARY_SUPPLEMENTNutrition supportNutritional replacement and bowel rest via enteral or parenteral nutrition

Timeline

Start date
2014-03-01
Primary completion
2017-06-01
Completion
2017-12-01
First posted
2013-04-11
Last updated
2015-06-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT01828892. Inclusion in this directory is not an endorsement.